A good deal of evidence both in vitro and in vivo now supports the hypothesis that oxidative modification of LDL enhances its atherogenicity in several ways. Unlike native LDL, it is cytotoxic; it is a chemoattractant for circulating monocytes; and it is recognized by the scavenger receptors of the macrophage, thus contributing to formation of foam cells in the fatty streak. The studies proposed will attempt to elucidate the mechanisms by which LDL undergoes oxidative modification, how the modified form interacts with cells of the artery wall and how these changes contribute to the pathogenesis of atherosclerosis. The potential role of lipoxygenases in oxidative modification will be studied in cultured cells, utilizing gene transfection and """"""""gene knockout"""""""" experiments with antisense mRNA to critically evaluate the role of lipoxygenases. The potential role of superoxide anion will be evaluated in continuing studies of normal monocytes and monocytes from patients lacking the NADPH oxidase system. Finally, the role of peroxidases and peroxides will be evaluated. Properties of the LDL particle that influence its susceptibility to oxidation will be studied, including its fatty acid composition, its initial content of lipoperoxides and its phopholipase A2 activity. In parallel, properties f the cell that may affect its ability to oxidatively modify will be studied. Recent evidence has been presented that LDL enriched in oleic acid is strongly resistant to oxidative modification. These studies will be pursued in an attempt to pinpoint the molecular mechanism underlying the resistance. Compounds that inhibit the ability of the cell to oxidatively modify will be studied. Evidence that an additional receptor(s) for uptake of oxidized LDL (in addition to the acetyl LDL receptor) will be pursued and attempts will be made to identify the """"""""natural"""""""" ligand(s) for these scavenger receptors. Finally, the metabolic consequences to the macrophage of binding and uptake of oxidatively modified LDL will be studied.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Specialized Center (P50)
Project #
5P50HL014197-24
Application #
3735932
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
24
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of California San Diego
Department
Type
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Guidez, F; Li, A C; Horvai, A et al. (1998) Differential utilization of Ras signaling pathways by macrophage colony-stimulating factor (CSF) and granulocyte-macrophage CSF receptors during macrophage differentiation. Mol Cell Biol 18:3851-61
Green, S; Steinberg, D; Quehenberger, O (1996) Cloning and expression in Xenopus oocytes of a mouse homologue of the human acylcoenzyme A: cholesterol acyltransferase and its potential role in metabolism of oxidized LDL. Biochem Biophys Res Commun 218:924-9
Ramprasad, M P; Terpstra, V; Kondratenko, N et al. (1996) Cell surface expression of mouse macrosialin and human CD68 and their role as macrophage receptors for oxidized low density lipoprotein. Proc Natl Acad Sci U S A 93:14833-8
Benz, D J; Mol, M; Ezaki, M et al. (1995) Enhanced levels of lipoperoxides in low density lipoprotein incubated with murine fibroblast expressing high levels of human 15-lipoxygenase. J Biol Chem 270:5191-7
Sambrano, G R; Steinberg, D (1995) Recognition of oxidatively damaged and apoptotic cells by an oxidized low density lipoprotein receptor on mouse peritoneal macrophages: role of membrane phosphatidylserine. Proc Natl Acad Sci U S A 92:1396-400
Ramprasad, M P; Fischer, W; Witztum, J L et al. (1995) The 94- to 97-kDa mouse macrophage membrane protein that recognizes oxidized low density lipoprotein and phosphatidylserine-rich liposomes is identical to macrosialin, the mouse homologue of human CD68. Proc Natl Acad Sci U S A 92:9580-4
Steinberg, D (1986) Studies on the mechanism of action of probucol. Am J Cardiol 57:16H-21H